Literature DB >> 33112276

When observational studies can give wrong answers: the potential of immortal time bias.

Olaf M Dekkers1,2, Rolf H H Groenwold1,3.   

Abstract

Immortal time bias should always be considered in an observational study if exposure status is determined based on a measurement or event that occurs after baseline. This bias can lead to an overestimation of an effect, but also to an underestimation, which is explained. Several approaches are illustrated that can be used to avoid immortal time bias in the analysis phase of the study; a time-dependent analysis to avoid immortal time bias optimizes the use of available information.

Mesh:

Year:  2021        PMID: 33112276     DOI: 10.1530/EJE-20-1124

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  5 in total

1.  Immortal Time Bias in the Analysis of Time-to-Event Data in Orthopedics.

Authors:  Dirk R Larson; Cynthia S Crowson; Katrina L Devick; David G Lewallen; Daniel J Berry; Hilal Maradit Kremers
Journal:  J Arthroplasty       Date:  2021-06-21       Impact factor: 4.435

2.  Prophylactic placement of inferior vena cava filters and the risk of death or venous thromboembolism in severe trauma patients: a retrospective study comparing two hospitals with different approaches.

Authors:  Thien Trung Tran; Haraldur Bjarnason; Jennifer McDonald; Nils Oddvar Skaga; Damon E Houghton; Brian Kim; Knut Stavem; Nils Einar Kløw
Journal:  Acta Radiol Open       Date:  2021-03-09

3.  Immortal time bias for life-long conditions in retrospective observational studies using electronic health records.

Authors:  Freya Tyrer; Krishnan Bhaskaran; Mark J Rutherford
Journal:  BMC Med Res Methodol       Date:  2022-03-27       Impact factor: 4.615

4.  A real-world analysis of nanoliposomal-irinotecan with 5-fluorouracil and folinic acid as third- or later-line therapy in patients with metastatic pancreatic adenocarcinoma.

Authors:  Jung Won Chun; Sang Myung Woo; Sang Hyub Lee; Jin Ho Choi; Namyoung Park; Joo Seong Kim; In Rae Cho; Woo Hyun Paik; Woo Jin Lee; Ji Kon Ryu; Yong-Tae Kim
Journal:  Ther Adv Med Oncol       Date:  2022-08-29       Impact factor: 5.485

5.  Association Between Testosterone Treatment and Risk of Incident Cardiovascular Events Among US Male Veterans With Low Testosterone Levels and Multiple Medical Comorbidities.

Authors:  Molly M Shores; Thomas J Walsh; Anna Korpak; Chloe Krakauer; Christopher W Forsberg; Alexandra E Fox; Kathryn P Moore; Susan R Heckbert; Mary Lou Thompson; Nicholas L Smith; Alvin M Matsumoto
Journal:  J Am Heart Assoc       Date:  2021-08-21       Impact factor: 5.501

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.